Publication | Open Access

Platelet-Activating Factor Blockade Inhibits the T-Helper Type 17 Cell Pathway and Suppresses Psoriasis-Like Skin Disease in K5.hTGF-β1 Transgenic Mice

MedicineCutaneous BiologyImmunologyK5.htgf-β1 Transgenic MiceClinical DermatologyPlatelet-activating Factor BlockadeDermatologyT-helper Type 17Immune SystemImmunotherapyExperimental DermatologyCell Signaling